AHCO in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with AHCO today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
AdaptHealth Corp. helps patients continue treatment at home after a hospital stay or a referral from a doctor or other care provider. Sleep apnea treatment is its largest business: it supplies machines that keep airways open during sleep, along with replacement masks, tubing and related services. It also supplies home oxygen and ventilation equipment, glucose monitors, insulin pumps and other home medical equipment.
Most revenue comes from selling products and replenishing supplies, with a single payment for each sale. Monthly payments for equipment such as oxygen systems, sleep therapy machines and hospital beds provide another substantial revenue stream. AdaptHealth delivers the products and bills insurers and patients directly. Private insurers supply most revenue, while Medicare and Medicaid are also important payors.
The business depends on referrals from hospitals, physicians and other care providers, although no single referral source accounts for a material share of revenue. Payment depends on insurers’ coverage rules, reimbursement rates and required documentation. Payors also limit how often patients can replace sleep therapy supplies, an important source of sales. AdaptHealth must maintain operating licenses and accreditation to serve patients and participate in relevant insurance programs.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
AdaptHealth's results hinge on reimbursed home equipment and recurring supplies; Lincare and Quipt Home Medical are important competitors missing from this list.
Accendra Health competes with AdaptHealth for patients needing home respiratory therapy, sleep-apnea equipment, diabetes supplies and other home medical products paid for by government programs and commercial insurers. Watch Accendra's revenue from these overlapping equipment and supply businesses for a read on the competition AdaptHealth faces.
Viemed Healthcare competes with AdaptHealth to supply insured patients with home ventilation, oxygen therapy and sleep-apnea equipment. Viemed earns respiratory equipment revenue mainly through monthly rentals, so its home ventilation revenue is worth watching alongside AdaptHealth's insurer-paid monthly equipment revenue.
Inogen competes with AdaptHealth by selling and renting oxygen concentrators directly to patients, while also selling equipment to home medical equipment providers. Watch those provider sales for a read on home oxygen demand, but distinguish them from direct patient sales and rentals, which compete with providers such as AdaptHealth.
Accendra Health, Inc. earningsACH
Accendra Health's report will show whether revenue is expanding or contracting in home-medical businesses it shares with AdaptHealth, offering a read on their competition for insured patients.
Watch Accendra Health's revenue in the overlapping home respiratory, sleep, diabetes-supply and other home-medical businesses. Growth would show Accendra expanding in markets where it competes with AdaptHealth for patients and product sales, pointing to stronger competitive pressure. A decline would mean less evidence of that pressure, but could reflect Accendra's business mix or execution rather than weaker overall demand.
AdaptHealth Corp. earningsThis company
AdaptHealth's report will show whether sleep-supply sales and respiratory patient growth can offset weakness in diabetes and home-care services while sustaining profit margins.
Read Sleep Health and Respiratory Health revenue alongside Diabetes Health and Wellness at Home revenue and the Adjusted EBITDA margin, a supplemental measure of adjusted operating earnings as a share of revenue. If sleep and respiratory growth offsets weakness in the other segments and the margin holds, patient volumes and supply sales are supporting the business. If revenue weakens or the margin falls further, payor mix, reimbursement or resupply pressures are outweighing that support.
Viemed Healthcare, Inc. earningsVMD
Viemed Healthcare's report will show how its mostly rental-based home respiratory revenue is changing, giving a demand and competition read-through for AdaptHealth's insurer-paid monthly equipment business.
Compare Viemed Healthcare's mostly rental-based respiratory equipment revenue with AdaptHealth's Respiratory Health revenue from equipment reimbursed at fixed monthly rates. Growth at both would support broader demand for home respiratory equipment. If Viemed grows while AdaptHealth's comparable revenue weakens, competition or differences in product mix may be involved; the figures alone cannot show that Viemed took patients from AdaptHealth.